Stock listing
Aquestive Therapeutics, Inc.
Selected listing: AQST · NASDAQ · USD · US
Aquestive Therapeutics, Inc. (NASDAQ:AQST), Health Technology. Latest release Sep 29, 2026: Aquestive Therapeutics Strengthens Board of Directors…
- Ticker
- NASDAQ:AQST
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. is a public company traded under the ticker AQST in the American market. It focuses on developing innovative therapeutics to address unmet medical needs.
Latest news from Aquestive Therapeutics, Inc.
Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly
September 29, 2026
Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
September 17, 2026
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
August 10, 2026
Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
July 29, 2026
Events
Research Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. company profile
View the public company page for Aquestive Therapeutics, Inc. on 6ix.
Aquestive Therapeutics, Inc. news
Read company news and market updates connected to Aquestive Therapeutics, Inc..
Aquestive Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Aquestive Therapeutics, Inc..